(MedPage Today) -- Two proteasome inhibitors developed for treating multiple myeloma, including the approved drug carfilzomib (Kyprolis), may also have directly beneficial effects on bone, researchers said. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment